IBCL-386: Rituximab-Vemurafenib Combination for the Treatment of Relapsed/Refractory Hairy Cell Leukemia


SEVİNDİK Ö. G., GEMİCİ A., MUTLU Y. G., BALIK AYDIN B., ÇAKIR A.

Society of Hematologic Oncology Eighth Annual Meeting, Houston, United States Of America, 9 - 12 September 2020

  • Publication Type: Conference Paper / Full Text
  • Doi Number: 10.1016/s2152-2650(20)30914-9
  • City: Houston
  • Country: United States Of America
  • Istanbul Medipol University Affiliated: Yes